| Q64108916 | A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges |
| Q92664092 | A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot |
| Q37443156 | Aseptic Meningitis Caused by Lassa Virus: Case Series Report. |
| Q24550962 | Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation |
| Q36630621 | Diagnosis of Lassa fever and the isolation and management of patients |
| Q34905744 | Ectoparasites and endoparasites of peridomestic house-rats in ile-ife, Nigeria and implication on human health |
| Q35870592 | Evaluation of Lassa antiviral compound ST-193 in a guinea pig model |
| Q42633699 | Experimental Lassa virus infection in the squirrel monkey |
| Q52590886 | Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. |
| Q35248863 | Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man |
| Q37064973 | Imported lassa fever in Germany: molecular characterization of a new lassa virus strain |
| Q40129746 | In silico prediction of B- and T- cell epitope on Lassa virus proteins for peptide based subunit vaccine design |
| Q33652265 | Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers |
| Q27485975 | Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa |
| Q36726640 | Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali |
| Q27485967 | Lassa fever in Onitsha, East Central State, Nigeria in 1974 |
| Q24674837 | Lassa fever in Panguma Hospital, Sierra Leone, 1973-6 |
| Q24290732 | Lassa fever in post-conflict sierra leone |
| Q27477741 | Lassa fever: retrospective diagnosis of two patients seen in Great Britain in 1971 |
| Q24647130 | Lassa fever: review of epidemiology and epizootiology |
| Q27485976 | Lassa immune serum |
| Q21092277 | Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation |
| Q24701722 | Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak |
| Q24599583 | On the front lines of Lassa fever |
| Q37083078 | Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. |
| Q24613450 | Pathogenesis of Lassa fever |
| Q33516227 | Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study |
| Q37201592 | Rat-atouille: A Mixed Method Study to Characterize Rodent Hunting and Consumption in the Context of Lassa Fever |
| Q91901545 | References |
| Q39052889 | Replicon system for Lassa virus |
| Q56897476 | Review of Biology and Replication |
| Q33414102 | Risk maps of Lassa fever in West Africa |
| Q56576756 | Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model |
| Q36630627 | Use of the complement fixation (CF) test in Lassa fever surveillance. Evidence for persistent CF antibodies |